In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 55570-60-0, name is 1,6-Naphthyridin-5-amine, introducing its new discovery. category: naphthyridine
Sunovion Pharmaceuticals Inc.
Provided herein are heteroaryl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as CNS disorders and metabolic disorders, including, but not limited to, e.g., neurological disorders, psychosis, schizophrenia, obesity, and diabetes
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 55570-60-0, and how the biochemistry of the body works.category: naphthyridine
Reference£º
1,379-Naphthyridine – Wikipedia,
1,8-Naphthyridine | C8H6N373 – PubChem